Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
honghua danpifen
- Development stage
- Unknown
- Lead developer
- Guangdong Zhongda Nanhai Marine Biotechnology Engineering
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Honghua Danpifen is a topical analgesic and anti-inflammatory formulation developed by Guangdong Zhongda Nanhai Marine Biotechnology Engineering Co., Ltd. It is primarily indicated for the treatment of acute soft tissue injuries, including sprains, bruises, and muscle pain. The product combines the therapeutic properties of Safflower (Honghua), which is traditionally used in Chinese medicine to promote blood circulation and resolve blood stasis, with Paeonol (Danpifen), a phenolic compound derived from Moutan Cortex known for its potent anti-inflammatory and analgesic activities. By inhibiting inflammatory mediators and improving local microcirculation, Honghua Danpifen effectively reduces swelling and alleviates pain at the site of injury. It is commonly administered as a spray for rapid absorption and localized relief.
- Brand names
- Honghua Danpifen Spray
- Other names
- Honghua DanpifenSafflower Paeonol Spray
02
Targets
NF-κB
Beyond the preview
Go deeper on honghua danpifen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on honghua danpifen.